Format

Send to

Choose Destination
Nature. 1994 Nov 10;372(6502):143-9.

Chromosomal translocations in human cancer.

Author information

1
MRC Laboratory of Molecular Biology, Cambridge, UK.

Abstract

Chromosomal abnormalities in tumours were recognized at the end of the last century but their significance has only recently become clear. Distinct translocations in leukaemias and in solid tumours lead to the activation of proto-oncogene products or, more commonly, creation of tumour-specific fusion proteins. The proteins in both categories are often transcription factors and thus disruption of transcriptional control plays a major role in the aetiology of cancer. Fusion proteins formed after chromosomal translocations are common in a range of tumour types; these are unique tumour antigens and are therefore potential targets for therapy design.

PMID:
7969446
DOI:
10.1038/372143a0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center